Global Leading Market Research Publisher QYResearch announces the release of its latest report “Skin Care Product Safety Testing – Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032”. Based on current situation and impact historical analysis (2021-2025) and forecast calculations (2026-2032), this report provides a comprehensive analysis of the global Skin Care Product Safety Testing market, including market size, share, demand, industry development status, and forecasts for the next few years.
Why are cosmetic manufacturers, contract testing laboratories, and regulatory affairs directors investing in skin care product safety testing? The global beauty industry (US$550–600 billion annually) faces three critical safety and regulatory challenges: consumer safety (skin care products must be free from harmful microorganisms, heavy metals, and allergens to prevent irritation, infection, and long-term health effects), regulatory compliance (FDA, EU Cosmetics Regulation (EC) No 1223/2009, China NMPA, Japan PMDA, and other global regulators require safety testing before market authorization), and product liability (manufacturers face lawsuits and brand damage from adverse reactions). The Cosmetics Safety Testing Center provides services such as cosmetic risk service testing, cosmetic safety assessment, cosmetic safety evaluation, and cosmetic safety testing. Skin care product safety testing encompasses microbiology testing (detecting harmful bacteria – E. coli, Pseudomonas, Staphylococcus aureus, Candida albicans), challenge testing (preservative efficacy testing to ensure product remains safe during consumer use), stability and compatibility testing (ensuring product maintains integrity under various temperature, humidity, and light conditions), and safety assessment (toxicological risk assessment of raw materials and finished products, including skin irritation, sensitization, phototoxicity, and systemic toxicity). Safety testing is mandatory for market access in all major global markets (US, EU, China, Japan, Korea, ASEAN, Brazil, etc.).
The global market for Skin Care Product Safety Testing was estimated to be worth US$ 1,067 million in 2025 and is projected to reach US$ 1,456 million by 2032, growing at a CAGR of 4.6% from 2026 to 2032. According to statistics from this research team, the total size of the global beauty industry in 2022 was approximately US$ 550 billion, of which sales of skin care products accounted for approximately US$ 150 billion, perfumes US$ 50 billion, makeup US$ 70 billion, and hair care products US$ 60 billion.
【Get a free sample PDF of this report (Including Full TOC, List of Tables & Figures, Chart)
https://www.qyresearch.com/reports/5743675/skin-care-product-safety-testing
Product Definition: What Is Skin Care Product Safety Testing?
Skin care product safety testing is a set of analytical and biological tests performed on raw materials, formulations, and finished products to ensure they are safe for human use. Key test categories include: (a) Microbiology Testing – detects and quantifies harmful microorganisms in raw materials and finished products. Tests: total viable count (TVC) – limits: <1,000 CFU/g (EU), <500 CFU/g (China, Japan); specific pathogens – E. coli, Pseudomonas aeruginosa, Staphylococcus aureus, Candida albicans (must be absent). (b) Challenge Test (Preservative Efficacy Test) – evaluates effectiveness of preservative system against microbial contamination during consumer use (repeated opening and closing). Test inoculates product with bacteria and fungi; measures log reduction over 28 days. (c) Stability and Compatibility Test – assesses product stability under accelerated aging conditions (temperature: 40–50°C, humidity: 75–85%, freeze-thaw cycles). Tests: pH, viscosity, color, odor, phase separation, active ingredient degradation. (d) Safety Assessment (Toxicological Risk Assessment) – evaluates potential for skin irritation, skin sensitization, phototoxicity (UV-induced toxicity), eye irritation, and systemic toxicity. Uses: in vitro methods (reconstructed human epidermis – RhE for skin irritation; human cell line activation test – h-CLAT for sensitization; bovine corneal opacity and permeability – BCOP for eye irritation), in silico methods (QSAR – quantitative structure-activity relationship for predicting toxicity), and in vivo methods (animal testing – banned in EU, China (post-2021), but still permitted in some markets). Safety assessments are conducted by qualified toxicologists and result in a Cosmetic Product Safety Report (CPSR) – mandatory for EU market access (Regulation EC 1223/2009). The global beauty industry in 2022 was approximately US$ 550 billion, with skin care products representing the largest category (US$ 150 billion).
Market Segmentation: Test Type and End-User
By Test Type (Service Category):
- Microbiology Testing – Largest segment (35–40% of market value). Routine testing for all raw materials and finished products.
- Stability and Compatibility Test – 25–30% of market value. Required for product development and shelf-life determination.
- Safety Assessment – 20–25% of market value. Toxicological risk assessment (CPSR).
- Challenge Test – 10–15% of market value. Preservative efficacy testing.
By End-User (Customer Type):
- Enterprise – Largest segment (85–90% of market value). Cosmetic manufacturers (global brands – L’Oréal, Estée Lauder, Shiseido, Procter & Gamble, Unilever), contract manufacturers, raw material suppliers.
- Individual – 10–15% of market value. Independent beauty brands, startups, entrepreneurs (small batch production, indie skincare lines).
Key Industry Characteristics Driving Strategic Decisions (2026–2032)
1. Regulatory Compliance as the Primary Demand Driver
The primary driver for skin care product safety testing is regulatory compliance for market access. Key regulations: EU Cosmetics Regulation (EC) No 1223/2009 – requires Cosmetic Product Safety Report (CPSR) prepared by a qualified safety assessor, including product information file (PIF), safety assessment, and labeling compliance. US FDA – requires safety substantiation (manufacturer responsibility) and labeling compliance (Fair Packaging and Labeling Act). China NMPA – requires safety testing at NMPA-approved laboratories for imported cosmetics (registration) and domestic cosmetics (filing). Japan PMDA – requires safety testing under Pharmaceutical and Medical Device Act (PMD Act). Korea MFDS – requires safety testing for functional cosmetics (whitening, anti-wrinkle, sun protection). Non-compliance results in: product recalls, import bans, fines (up to US$1 million in EU, US$500,000 in China), and criminal liability for serious safety incidents. The 4.6% CAGR reflects steady demand from the global beauty industry (3–4% annual growth) plus increased testing per product (more formulations, natural/preservative-free products requiring additional stability and challenge testing).
2. Technical Challenge: Alternative Testing Methods (Animal Testing Bans)
The primary technical challenge for skin care product safety testing is transitioning from animal testing (in vivo) to alternative methods (in vitro, in silico) while maintaining regulatory acceptance. Animal testing bans – EU (2013, complete ban), China (post-2021 – lifted mandatory animal testing for general cosmetics, but still required for certain claims and imported products), India (2014), Norway, Israel, UK, Switzerland, South Korea (2018), New Zealand. Alternative methods accepted by OECD (Organisation for Economic Co-operation and Development) and regulatory authorities: (i) skin irritation – Reconstructed Human Epidermis (RhE) test (OECD TG 439) – EpiSkin, SkinEthic, LabCyte EPI-MODEL; (ii) skin sensitization – ARE-Nrf2 luciferase test (OECD TG 442D) – KeratinoSens; human cell line activation test (OECD TG 442E) – h-CLAT; (iii) eye irritation – Bovine Corneal Opacity and Permeability (OECD TG 437), Reconstructed Human Cornea-like Epithelium (OECD TG 492); (iv) phototoxicity – 3T3 Neutral Red Uptake (OECD TG 432). However, alternative methods are not yet validated for all endpoints (e.g., repeated dose toxicity, reproductive toxicity, carcinogenicity), requiring weight-of-evidence approaches or waivers. Testing laboratories must invest in cell culture facilities, assay validation, and regulatory expertise to offer compliant alternative testing services.
3. Industry Segmentation: EU vs. US vs. China vs. Other Markets
The skin care product safety testing market segments by geographic regulatory framework.
EU market testing – 30–35% of market value, 4–5% CAGR. Stringent requirements: CPSR by qualified safety assessor (toxicologist), PIF maintenance, animal testing ban. Higher testing costs (US$5,000–20,000 per product).
US market testing – 25–30% of market value, 3–4% CAGR. No pre-market approval, but safety substantiation required (manufacturer responsibility). Lower testing costs (US$2,000–10,000 per product), but higher liability risk.
China market testing – 20–25% of market value, 5–6% CAGR – fastest-growing. Mandatory testing at NMPA-approved laboratories for registration/filing. Post-2021: animal testing optional for general cosmetics (except for special use cosmetics – whitening, anti-wrinkle, sun protection, hair dyes). Testing costs: US$3,000–15,000 per product.
Other markets (Japan, Korea, ASEAN, Brazil, etc.) – 10–15% of market value, 4–5% CAGR.
4. Recent Market Developments (2025–2026)
- Intertek (October 2025) launched a “Green Chemistry” safety testing service for skin care products, assessing potential endocrine disruptors (phthalates, parabens, BPA, UV filters) and environmental toxicity (aquatic toxicity, biodegradation) – targeting brands with sustainability commitments.
- SGS (November 2025) received NMPA approval for cosmetic safety testing in China (expanded scope), now offering microbiology, stability, challenge, and safety assessment for imported and domestic cosmetics (50+ new products tested per month).
- Eurofins (December 2025) introduced an AI-based safety assessment platform (Eurofins ToxAI) using machine learning (trained on 100,000+ toxicology studies) to predict skin sensitization, irritation, and phototoxicity from chemical structure (QSAR), reducing animal testing by 70–80% and assessment time from weeks to hours.
- European Commission (January 2026) published updated “Cosmetics Regulation (EC) No 1223/2009″ annexes, adding testing requirements for endocrine disruptors (ED assessment) and microplastics (biodegradation testing) – expanding testing scope.
- China NMPA (February 2026) issued new “Safety Technical Standards for Cosmetics” (2026 edition), requiring additional testing for heavy metals (mercury, lead, arsenic, cadmium – lower limits), prohibited substances (2,000+ substances), and allergens (26 fragrance allergens – labeling requirement).
5. Exclusive Observation: The Rise of “Clean Beauty” and Natural Preservative Testing
The “clean beauty” trend (products without parabens, phthalates, sulfates, synthetic fragrances, etc.) is driving increased demand for stability and challenge testing. Natural preservatives (essential oils – rosemary, tea tree, thyme; organic acids – benzoic acid, sorbic acid; fermentation-derived – gluconolactone, caprylyl glycol) are less effective than synthetic preservatives (parabens, phenoxyethanol), requiring more rigorous challenge testing (preservative efficacy test – PET). Additionally, natural preservatives can degrade faster, requiring extended stability testing (12–24 months vs. 6–12 months for synthetic). For testing laboratories, “clean beauty” formulations represent 20–30% of new product submissions (up from 5–10% in 2020), with higher testing volume (multiple iterations to optimize preservative system). For cosmetic manufacturers, natural preservative testing adds 30–50% to safety testing costs.
Key Players
Intertek, SGS, Eurofins, CIRS GROUP, UL, Bureau Veritas, TUV SUD, Dekra, ALS Global, Centre Testing International, Korea Testing & Research Institute, KOTITI, HQTS, Global Inspection Managing, TÜV Rheinland, CAS Testing Technical Services, Spectro Analytical Labs, CMA Testing, Jasan Cosmetic Laboratories, Cosmetic Testing Lab, Microchem Laboratory, CE.Way Regulatory Consultants, QACS – The Challenge Test Laboratory, Contract Laboratory, AEMTEK Laboratories, Hangzhou C&K Testing Technic Co., Ltd, Kirei-Testing-Labo.
Strategic Takeaways for Cosmetic Manufacturers, Regulatory Affairs Directors, and Investors
- For cosmetic manufacturers (brands, contract manufacturers): Allocate 1–3% of product development budget to safety testing (US$5,000–20,000 per product for EU/China; US$2,000–10,000 for US). For “clean beauty” formulations, budget additional 30–50% for challenge testing (natural preservatives). For global distribution, test to the most stringent standard (EU – CPSR by qualified assessor) and leverage results for other markets (US, China, Japan).
- For regulatory affairs directors: Stay current on alternative testing methods (OECD validated) and regulatory acceptance (EU, China NMPA, US FDA). Use AI-based safety assessment (QSAR) for early screening of raw materials (reduce animal testing, accelerate development). For China market, use NMPA-approved testing laboratories (avoid import delays).
- For investors: The 4.6% CAGR for the overall market understates growth in the China market subsegment (5–6% CAGR), the “clean beauty” natural preservative testing subsegment (8–10% CAGR), and the endocrine disruptor assessment subsegment (6–8% CAGR). Target testing laboratories with (a) global regulatory approvals (EU CPSR, China NMPA, US FDA), (b) alternative testing capabilities (in vitro, in silico – OECD validated), (c) “clean beauty” testing expertise (natural preservatives, challenge testing), and (d) AI/QSAR platforms (differentiation). The Cosmetics Safety Testing Center carries out services including cosmetic risk testing, safety assessment, safety evaluation, and safety testing – essential for global beauty brands.
Contact Us:
If you have any queries regarding this report or if you would like further information, please contact us:
QY Research Inc.
Add: 17890 Castleton Street Suite 369 City of Industry CA 91748 United States
EN: https://www.qyresearch.com
E-mail: global@qyresearch.com
Tel: 001-626-842-1666 (US)
JP: https://www.qyresearch.co.jp
